×
Skip to content
ShareCafe

  • Home
  • Shares
  • Financial Products
  • Video
  • Contributors
  • Community
  • About us
  • Facebook
  • Twitter
  • YouTube
  • RSS
Main Menu

Tim Boreham

Tim Boreham edits The New Criterion. Many readers will remember Boreham as author of the Criterion column in The Australian newspaper, for well over a decade. He also has more than three decades' experience of business reporting across three major publications.

Shares

Small Cap Dividend Stocks You Probably Have Never Heard Of

December 16, 2019December 16, 2019 - by Tim Boreham

For yield chasing investors, the small-cap sector can offer attractive dividends based on sound and sustainable earnings. Many of these dividends delights are virtually unheard of, which means they haven’t been bid up as aggressively as the handful of blue-chip stocks that investors flock to.

Read More
Shares / Technology

The Opportunities In – And Pitfalls Of – The Data Storage Sector

December 4, 2019December 4, 2019 - by Tim Boreham

While demand for shared cloud-based data storage shows no signs of abating in a hurry, local data centre oversupply is looming as a short term issue.

Read More
Shares

Four Small Cap Recovery Stocks

November 29, 2019November 29, 2019 - by Tim Boreham

When it comes to small caps that have lost their way, it’s all too easy for investors to banish them from their portfolios and move to fresher pastures. In fact it’s quite cathartic. But don’t be so hasty: enterprises rarely evolve in a neat linear fashion.

Read More
Commodities / Shares

Is Copper Due For A Run?

November 21, 2019November 21, 2019 - by Tim Boreham

The bellwether of global economic activity, copper has pretty much marked time over the last 12 months price-wise – a fair reflection of the sluggish conditions.

Read More
Markets / Shares

How To Benefit From Short Selling

November 14, 2019November 14, 2019 - by Tim Boreham

With an increasing number of activist short selling campaigns targeting stocks perceived as overvalued, nervous directors will be asking ‘who’s next?’

Read More
Shares

In Any Language, English Testing Is A Lucrative Market

November 11, 2019November 11, 2019 - by Tim Boreham

The federal government may have succeeded in cleaning up the woeful private vocational education sector, but now faces a fresh issue in its quest to protect the $35 billion foreign student trade.

Read More
LICs / Shares

The Benefits And Risks Of Credit-Focused Listed Investment Trusts

October 18, 2019October 18, 2019 - by Tim Boreham

With investors clamouring for better yields than paltry returns on cash deposits, the world’s top debt whisperers have obliged with an expanding cluster of ASX-listed funds to give retail punters an exposure to a $US2 trillion global sector hitherto the preserve of institutions and sophisticated investors.

Read More
Shares

Picking The One Cent Wonders That Could Become Dollar Dazzlers

October 3, 2019October 3, 2019 - by Tim Boreham

When a stock is trading at a fraction of a cent, it’s usually a message for investors to abandon all hope and sell for the tax losses while they can. But ‘penny dreadful’ shares can sometimes rise from the ashes.

Read More
Shares

Two Ways To Play The Pain Medication Game

September 26, 2019 - by Tim Boreham

Massive legal settlements in the US have highlighted the scourge of opioid abuse, but Australian producer Palla Pharma is confident the drug class will remain the world’s foremost pain medication. Meanwhile, Paradigm Pharmaceuticals presents an alternative.

Read More
Commodities / Shares

Behind The Lithium Market Meltdown

September 19, 2019September 19, 2019 - by Tim Boreham

The stronger-for-longer lithium story is not exactly panning out as such, with a global oversupply emerging and the upbeat blue sky stories supplanted by tales of woe from the emerging producers. The same thing’s happening with that other wonder battery metal, graphite.

Read More
Shares

The Genuine Investor Interest Behind The Fake Meat Trend

September 11, 2019September 11, 2019 - by Tim Boreham

Meat substitute stocks are all the rage in the US, but locally there’s a more limited bill of fare for investors – for the time being at least.

Read More
Shares

Two Retail Suppliers To Watch

August 29, 2019August 29, 2019 - by Tim Boreham

Being a supplier to the big bad supermarkets hasn’t been a fun place over the last decade, but two of the sector’s stalwarts are fighting their way out of the retailing wilderness.

Read More
Shares

The ASX Stocks Storming The US Military Establishment (Or Trying To)

August 22, 2019August 22, 2019 - by Tim Boreham

A paradox of the Pentagon is that it can start a war in about five minutes, but when it comes to selecting contractors to supply the materiel the process drags out for years. But some ASX stocks are achieving success in their assault on the military establishment.

Read More
Property / Shares

Should Investors Squeeze Into The Co-Working Collaborative Zone?

August 14, 2019August 22, 2019 - by Tim Boreham

Shared office space used to be just that: cheap digs for start-up enterprises. Now it’s a burgeoning property sub-sector.

Read More
Shares

The Emerging Winners In ‘Cannabis Corner’

August 8, 2019 - by Tim Boreham

Hampered to date by a lack of doctor awareness, perception issues and a dearth of approved treatments, the local medicinal cannabis sector is showing the first buds of meaningful growth.

Read More
Shares

The Two Stocks Motorists Love To Hate

August 1, 2019August 1, 2019 - by Tim Boreham

Speeding motorists and errant parkers hope they will never do business with Smart Parking and Redflex. But should investors?

Read More
Commodities / Shares

Sniffing Out Golden Opportunities On The ASX

July 25, 2019July 25, 2019 - by Tim Boreham

Bullion’s romp beyond the record $2000 an ounce level in Aussie dollar terms has prompted investors to take a closer look at the pantheon of ASX-listed local gold producers – despite some problems in the mid-tier that have tarnished the sector.

Read More
Shares

Investing In The Egaming And Esports Boom

July 17, 2019July 17, 2019 - by Tim Boreham

Egaming (or esports) is big business globally and four ASX minnows are jostling for their turn at the console.

Read More
Shares

The Companies Tackling Cyber Security In Schools

July 12, 2019July 12, 2019 - by Tim Boreham

As well as the French, the Victorian and NSW governments are banning mobile phone usage in schools. While the jury’s out on how effective the measures will be, two listed minnows are eyeing the opportunities.

Read More
Shares

A Reality Check For The Buy Now Pay Later Sector, Or The Beginning Of The Beginning?

June 26, 2019June 26, 2019 - by Tim Boreham

The Australian Stock Exchange’s status as the global home of listed buy now pay later stocks is under scrutiny and yet the bandwagon keeps rollin’ on.

Read More
Shares

Two Food Plays With Problems As Well As Potential

June 19, 2019 - by Tim Boreham

With a new backer, Food Revolution Group is taking an aggressive approach to the Middle Kingdom. Further up the food chain, investors are trying to work out whether Costa Group’s issues are cyclical or more systemic

Read More
Shares

Who Is The Next Takeover Target?

June 13, 2019June 13, 2019 - by Tim Boreham

The takeover activity at the top end of town is permeating down to the small to mid-sized sector, raising the perennial question of who might be next to garner interest from cashed-up or merely opportunistic acquirers.

Read More
Shares

ASX Satellite Plays That Are Out Of This World

June 6, 2019June 6, 2019 - by Tim Boreham

Building and launching satellites has never been cheaper and easier, spurring a constellation of ASX-listed satellite plays

Read More
Commodities / Shares

Can Producers Have Their Yellowcake And Eat It Too?

May 31, 2019May 31, 2019 - by Tim Boreham

Waiting for the depressed uranium market to turn is like waiting on the platform for a tardy train, but the fundamentals for a recovery are in place.

Read More
Shares

Tapping The Home Automation Boom

May 22, 2019May 22, 2019 - by Tim Boreham

Hey Google! What ASX small caps are exposed to the unfolding home automation boom? The answers are below

Read More
Shares

Why This Tech Fund Trades At A Steep Discount To Underlying Assets

May 10, 2019May 10, 2019 - by Tim Boreham

The only pure-tech listed investment company on the ASX, Bailador Technology Investments (BTI) 93c adheres to a simple charter of providing investors with a one-stop exposure to emerging local innovators with a decent chance of cracking a global market in the same vein as Afterpay, Atlassian or Wisetech Global.

Read More
Shares

Should Automotive Holdings Investors Trade In Their Shares?

May 1, 2019May 1, 2019 - by Tim Boreham

The mooted merger of Australia’s biggest and second-biggest car dealers groups make sense, but there are still some curves and potholes to navigate.

Read More
Commodities / Shares

Is High Purity Alumina The Next Battery Gold Rush?

April 24, 2019April 24, 2019 - by Tim Boreham

Cobalt? Passe. Lithium? Soo yesterday. Graphite? Get with the program, please: high purity alumina is the vogue battery metal.

Read More
Shares

Mission (Almost) Impossible To Find Small-Cap Value

April 11, 2019April 11, 2019 - by Tim Boreham

Your columnist declares Mission Accomplished with his quest to find three industrial small-cap stocks that represent deep value.

Read More
Shares

Three ASX Water Plays Wading Into The Global Purification Market

April 4, 2019April 4, 2019 - by Tim Boreham

Water water all around, but not a drop of drinkable stuff to be found. These three ASX stocks are tackling the emerging global shortage of potable water

Read More
Shares

The Booming Debt Consolidation Sector

March 28, 2019March 27, 2019 - by Tim Boreham

Amid the ongoing fallout of the Hayne banking royal commission, another area of financial services has been subject to quieter reforms: the thriving market for debt agreement and debt consolidation arrangements.

Read More
Shares

Dairy Processors Milk Their Farmers As Drought Hits

March 21, 2019 - by Tim Boreham

Long synonymous with struggling dairy farmers and perpetual milk glut, Australia’s dairy market is rapidly tightening as the producers compete more aggressively for supply that has been eroded because of drought.

Read More
Shares

Not So Fertile Ground For IVF Leader

March 13, 2019February 26, 2020 - by Tim Boreham

The flagging housing market and sagging consumer sentiment ahead of the federal and NSW elections have affected the performance of an unlikely ASX-listed exponent – the assisted reproduction outfit Virtus Health (VRT, $3.98).

Read More
Shares

Where Does All The Grass Go? The Dilemma For ASX-Listed Pot Stocks

March 6, 2019 - by Tim Boreham

Amid the rush by the ASX listed ‘pot stocks’ to grow medical cannabis, the market has overlooked a key question: where will all the therapeutic hooch be processed?

Read More
Shares

Two Travel Small Caps Worth A Test Ride

March 1, 2019March 1, 2019 - by Tim Boreham

Recent market entrant Jayride has ambitions to become the ‘bookings.com’ of airport transit services. Elsewhere in the travel sector, the expansive Sealink is navigating choppy waters as it awaits the outcome of a contract to run Sydney’s ferries.

Read More
Shares

Satellite Stocks Shooting For The Stars

February 22, 2019February 22, 2019 - by Tim Boreham

Two ASX-listed satellite plays are striving to reach for the stars, but to succeed they need to convince investors that a previous high-profile failure in the sector was an aberration

Read More
Shares

Time To Bank On The Small Fry?

February 13, 2019 - by Tim Boreham

Not everything’s going right for the smaller banks, but the findings of the Hayne Royal Commission present a perfect opportunity to woo discontented Big Four customers. Should investors follow?

Read More
Shares

Two ‘True Blue’ Small Cap Tech Stocks

February 6, 2019February 8, 2019 - by Tim Boreham

As with online dating, seeking a suitable partner can be a vexed pursuit for emerging Australian tech plays. As the experience of these two ‘true blue’ stocks attest, the partnering process involves many twists and turns.

Read More
Shares

Fishing For Bargains In The Small Cap Sea

January 31, 2019January 31, 2019 - by Tim Boreham

For a sector that has heaped heartbreak on investors over the years, ASX-listed seafood exposures now present an ocean of choice to investors. Most of the expanding school of piscatorial plays are export-oriented – or aspire to be – and leverage Australia’s image of having pristine waters.

Read More
Shares

Poised For Recovery? Ten Beaten Down Small Caps That Might Rock In 2019

January 23, 2019January 23, 2019 - by Tim Boreham

With so many investment babies being thrown out with the murky bathwater, do opportunities abound for the fearless, especially given the market’s positive start to the year?

Read More

Posts navigation

Previous 1 2 3 … 5 Next
  • Bell Potter LIC Weekly: Quality Growth – Going, Going, Gone
  • S32 – Citi rates the stock as Buy
  • ALQ – Morgan Stanley rates the stock as Equal-weight
  • SLC – Morgans rates the stock as Add
  • FPH – Citi rates the stock as Buy
  • ALQ – Macquarie rates the stock as Outperform
  • NAN – Morgans rates the stock as Add
  • Lunch Report: 26 May, 2022

Subscribe to ShareCafe

The daily resource for hands-on investors. Market insights and investment ideas delivered free to your inbox.

Copyright 2020 Informed Investor Pty Ltd ABN 42 162 871 589. All rights reserved.
No portion of this website maybe reproduced, copied or in any way released without written permission.
Share Cafe is a Corporate Authorised Representative (001283561) of Sequoia Asset Management Pty Limited who holds an Australian Financial Services Licence (Number: 341506)

Terms of Service | Privacy Policy | Contact | Advertise

DOWNLOAD RESEARCH REPORT

4Q reveals more focus on profit and cash flow

• LBY’s 4Q FY22 quarterly activities update showed continued solid growth in top line metrics, albeit slowing, with GMV of NZ$203m (+26% on pcp) and income of NZ$12.1m (+23% on pcp).
• Net Transaction Margin (NTM) disappointed at -0.5%, due to further increase in credit losses from 4.0% to 4.9% of GMV. However, new fraud and credit risk management tools have seen losses recover materially with NTM back to 1.2% in March and LBY is confident of further recovery in coming months.

    SMSFBrokerFinancial Adviser

    Please prove you are human by selecting the Cup.

    DOWNLOAD RESEARCH REPORT

    Signs MOU with Ford Company – Kachi is now sold out!

    Lake Resources (LKE. ASX) – LKE has signed two non-binding MOU’s in the space of 10 days. Ford Company (Ford) has signed an MOU for ~25,000t/year and last week Hanwa, a Japanese commodity trader signed a MOU for up to 25,000t/year. Subject to execution, this is an amazing feat as Ford and Hanwa are prepared to enter into longer-term strategic partnerships with LKE. Commercial negotiations are still ongoing but are expected, especially if Ford & Hanwa inject new equity into LKE, to further de-risk the project financing & thus ensure LKE and Kachi are fully funded.

      SMSFBrokerFinancial Adviser

      Please prove you are human by selecting the Flag.

      DOWNLOAD RESEARCH REPORT

      Strategic Vanadium-battery growth with Titanium & Iron earnings resiliency

      TNG Ltd is an ASX-listed technology owner and developer of the world-class Mount Peake near-surface vanadiferous titanomagnetite deposit. To unlock value, TNG will concentrate ore from its central Northern Territory mine for processing through its patented TIVAN® process produce three premium quality revenue streams: hi-purity vanadium pentoxide (V2O5) for steel alloys and Vanadium Redox Flow batteries, a quality titanium pigment for paints and a premium steel input with >64%Fe iron ore fines.

        SMSFBrokerFinancial Adviser

        Please prove you are human by selecting the Cup.

        Promising exploration and development update while SOP prices continue to rise

        Two recent gravity surveys have considerably exceeded expectations and revealed potential for extensions to the existing MRE at Lake Throssell, plus a material growth opportunity at Lake Yeo. This reinforces the potential for a multi-decade, Tier-1 SOP production hub based around Lake Throssell.

        TMG is currently completing work towards the PFS due early 2023, including drilling to start in Q3 2022, evaporation trials and permitting activities. Results from these programs will support the PFS and any future resource upgrade.

        Benchmark SOP prices have risen to ~US$940/t due to recent geopolitical developments. The Oct 2021 Scoping Study assumed a SOP price of US$550/t and contained a sensitivity analysis showing every 10% increase in price drives a +$144m increase in the project NPV of $364m. The c.70% increase above the Scoping Study thus implies a project NPV of ~$1.4bn.

        DOWNLOAD RESEARCH REPORT

          SMSFBrokerFinancial Adviser

          Please prove you are human by selecting the Car.

          DOWNLOAD RESEARCH REPORT

          Biopharmas Hit, but Buying Opportunities Created

          The news being reported about the performance of biotechnology has been dour, to say the least, for some time now. Those dour articles have been deserved with the iShares Biotechnology Exchange-Traded Fund down 25% and the SPDR® S&P® Biotech ETF is down 45% from their highs. However, those articles are backward-looking, and successful investors need to be looking forward.

          Recently, however, an article in Nature Reviews Drug Discovery caught our eye which we believe should point the way forward for the vast majority of Australian biotechnology investors. This article indicates that, at least, two companies, Antisense Therapeutics (ANP) and Kazia Therapeutics (KZA), are right in the sweet spot in terms of the future of drug development.

            SMSFBrokerFinancial Adviser

            Please prove you are human by selecting the Heart.

            DOWNLOAD RESEARCH REPORT

            Biopharmas Hit, but Buying Opportunities Created

            The news being reported about the performance of biotechnology has been dour, to say the least, for some time now. Those dour articles have been deserved with the iShares Biotechnology Exchange-Traded Fund down 25% and the SPDR® S&P® Biotech ETF is down 45% from their highs. However, those articles are backward-looking, and successful investors need to be looking forward.

            Recently, however, an article in Nature Reviews Drug Discovery caught our eye which we believe should point the way forward for the vast majority of Australian biotechnology investors. This article indicates that, at least, two companies, Antisense Therapeutics (ANP) and Kazia Therapeutics (KZA), are right in the sweet spot in terms of the future of drug development.

              SMSFBrokerFinancial Adviser

              Please prove you are human by selecting the House.

              DOWNLOAD RESEARCH REPORT

              Coal prices up, debt down – It’s payback time

              Strong 1H22 but the real story unfolds in 2H22.

              TerraCom made two announcements to the ASX on the 28th February – the first was their 2021 Half Year 2021 result which indicated that TER continues to report strong operating metrics as well as enjoying buoyant thermal coal markets which is allowing them to pay down debt at an accelerated pace.

                SMSFBrokerFinancial Adviser

                Please prove you are human by selecting the Heart.

                DOWNLOAD RESEARCH REPORT

                Hitting goals – Making four material announcements

                We initiated on Magnis Energy Technologies (MNS.ASX) in December 2021 and since then, MNS has made four material announcements. Firstly; a conditional offtake contract for 600,000t of graphite concentrate from the Tanzanian Nachu Project (net 100%) was signed with Traxys, a global
                commodities merchant with annual revenue of ~US$6Bn; secondly; semi autonomous production has started at battery gigafactory iM3NY, thirdly;
                exciting Extra Fast Charge battery tests were reported and most recently, the game changing launch of the Lithium Slim Energy Reserve battery platform, which supports C4V’s growing EFC capability.

                  SMSFBrokerFinancial Adviser

                  Please prove you are human by selecting the Star.

                  DOWNLOAD RESEARCH REPORT

                  Increasing our Target

                  Despite the lower realised oil and gas price, which fell by 5.4% and 19.7% respectively in August, Calima managed to show improvement in its key business metrics.

                  We expect higher production in November due to the contribution by the new Thorsby wells which will be drilled in August/September which will see Calima meet its 2021 production guidance of 4,500 boe/d.

                    SMSFBrokerFinancial Adviser

                    Please prove you are human by selecting the Star.

                    DOWNLOAD RESEARCH REPORT

                    Emerging Financial Wealth Advisory Group

                    WT Financial Group Limited (WTL) is a growing diversified financial services company, founded in 2010 and listed on the Australian Stock Exchange (ASX) in 2015. Its advice and product offerings are delivered primarily through a group of independent financial advisers operating as authorised representatives of WTL under its Wealth Today Pty Ltd (Wealth Today) and Sentry Group Pty Ltd (Sentry Group) dealer group operations. It has around 275 advisers across more than 200 financial advice practices Australia-wide. It also operates a direct-to-consumer operation under its Spring Financial Group brand.

                      SMSFBrokerFinancial Adviser

                      Please prove you are human by selecting the Plane.

                      DOWNLOAD RESEARCH REPORT
                      Immutep Taking the Fight to Cancer

                      In May 2021, Corporate Connect analyst Marc Sinatra published a comprehensive research report on ASX-listed biotech Immutep Ltd (ASX: IMM). So impressed was he with IMM that Corporate Connect felt it imperative that a follow-up report be released placing a valuation on the company, because the market was not seeing the vast potential of eftilagimod alpha (efti).

                      This follow-up report has been released today. Using comparables, after adding cash back to their EV estimate and dividing by the total number of issued shares, Corporate Connect now places the fair value of an Immutep share at $A2.20.

                        SMSFBrokerFinancial Adviser

                        Please prove you are human by selecting the Key.

                        DOWNLOAD RESEARCH REPORT

                        Phillips 66 to acquire 16% in NVX – 12-month target price rises 7% through project de-risking

                        Phillips 66 (PSX) has entered into an agreement with NVX to acquire 77.9m new shares for US$150m (A$203m). PSX is the worlds largest producer of speciality petroleum coke a precursor for battery grade synthetic graphite anode materials found with an Enterprise Value of US$47.5Bn and assets of US$57Bn.

                          SMSFBrokerFinancial Adviser

                          Please prove you are human by selecting the House.

                          DOWNLOAD RESEARCH REPORT

                          Market leading lifelong learning platform technology company in Australia and SE Asia

                          PayGroup (PYG) delivers multi-country BPO services and cloud SaaS HCM solutions, assisting companies to manage employees in multiple, complex jurisdictions. The company has many growth opportunities, including new clients, new jurisdictions, new products, partner expansion, and new revenue sources. PYG’s scalable business model allows operating leverage and with savings from in-housing third party technology, support margin expansion.

                            SMSFBrokerFinancial Adviser

                            Please prove you are human by selecting the Car.

                            DOWNLOAD RESEARCH REPORT

                            Market leading lifelong learning platform technology company in Australia and SE Asia

                            OpenLearning (OLL) is a higher education technology company that operates a scalable online learning platform through a software-as-a-service (SaaS) business model and provides a global marketplace of high quality courses for learners of all levels. Its primary customers are education providers based in Australia and South-East Asia (primarily Malaysia). OLL started operations in Australia in 2012 and expanded to Malaysia in 2015, Singapore in 2018, and recently also Indonesia.

                              SMSFBrokerFinancial Adviser

                              Please prove you are human by selecting the Key.